Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Ocrelizumab in multiple sclerosis: risks and benefits.
CHMP recommends granting a marketing authorization for Santhera's Raxone® for the treatment of Leber's Hereditary Optic Neuropathy (LHON)
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Corticosteroids for treating optic neuritis.
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past.
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.
Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Patient page. Multiple sclerosis and vitamin D.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
Influence of cigarette smoking on white matter in patients with clinically isolated syndrome as detected by diffusion tensor imaging.
Pages
« first
‹ previous
…
116
117
118
119
120
121
122
123
124
…
next ›
last »